292. Murray C. A., Leong W. L., McCready D. R., Ghazarian D. M. Histopathological patterns of melanoma metastases in sentinel lymph nodes // J Clin Pathol. ‒ 2004. ‒ T. 57, № 1. ‒ C. 64-7.
293. Vitoux D., Mourah S., Kerob D., Verola O., Basset-Seguin N., Baccard M., Schartz N., Ollivaud L., Archimbaud A., Servant J. M., Revol M., Toubert M. E., Podgorniak M. P., Plassa F., Porcher R., Lebbe C. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases // Arch Dermatol. ‒ 2009. ‒ T. 145, № 10. ‒ C. 1105-13.
294. Rimoldi D., Lemoine R., Kurt A. M., Salvi S., Berset M., Matter M., Roche B., Cerottini J. P., Guggisberg D., Krischer J., Braun R., Willi J. P., Antonescu C., Slosman D., Lejeune F. J., Lienard D., Groupe Melanome L. Detection of micrometastases in sentinel lymph nodes from melanoma patients: direct comparison of multimarker molecular and immunopathological methods // Melanoma Res. ‒ 2003. ‒ T. 13, № 5. ‒ C. 511-20.
295. Baisden B. L., Askin F. B., Lange J. R., Westra W. H. HMB-45 immunohistochemical staining of sentinel lymph nodes: a specific method for enhancing detection of micrometastases in patients with melanoma // Am J Surg Pathol. ‒ 2000. ‒ T. 24, № 8. ‒ C. 1140-6.
296. Lukowsky A., Bellmann B., Ringk A., Winter H., Audring H., Fenske S., Sterry W. Detection of melanoma micrometastases in the sentinel lymph node and in nonsentinel nodes by tyrosinase polymerase chain reaction // J Invest Dermatol. ‒ 1999. ‒ T. 113, № 4. ‒ C. 554-9.
297. Vrotsos E., Alexis J. Can SOX-10 or KBA.62 Replace S100 Protein in Immunohistochemical Evaluation of Sentinel Lymph Nodes for Metastatic Melanoma? // Appl Immunohistochem Mol Morphol. ‒ 2016. ‒ T. 24, № 1. ‒ C. 26-9.
298. Voit C. A., Oude Ophuis C. M., Ulrich J., van Akkooi A. C., Eggermont A. M. Ultrasound of the sentinel node in melanoma patients: echo-free island is a discriminatory morphologic feature for node positivity // Melanoma Res. ‒ 2016. ‒ T. 26, № 3. ‒ C. 267-71.
299. Voit C. A., Gooskens S. L., Siegel P., Schaefer G., Schoengen A., Rowert J., van Akkooi A. C., Eggermont A. M. Ultrasound-guided fine needle aspiration cytology as an addendum to sentinel lymph node biopsy can perfect the staging strategy in melanoma patients // Eur J Cancer. ‒ 2014. ‒ T. 50, № 13. ‒ C. 2280-8.
300. Voit C. A., van Akkooi A. C., Schafer-Hesterberg G., Schoengen A., Schmitz P. I., Sterry W., Eggermont A. M. Rotterdam Criteria for sentinel node (SN) tumor burden and the accuracy of ultrasound (US)-guided fine-needle aspiration cytology (FNAC): can US-guided FNAC replace SN staging in patients with melanoma? // J Clin Oncol. ‒ 2009. ‒ T. 27, № 30. ‒ C. 4994-5000.
301. Voit C., Schoengen A., Schwurzer-Voit M., Weber L., Ulrich J., Sterry W., Proebstle T. M. The role of ultrasound in detection and management of regional disease in melanoma patients // Semin Oncol. ‒ 2002. ‒ T. 29, № 4. ‒ C. 353-60.
302. АЛЛАХВЕРДЯН Г. С., ЧЕКАЛОВА М. А., КОКОСАДЗЕ Н. В. ВОЗМОЖНОСТИ УЛЬТРАЗВУКОВОГО ИССЛЕДОВАНИЯ В РАННЕЙ ДИАГНОСТИКЕ МЕТАСТАЗОВ МЕЛАНОМЫ КОЖИ В РЕГИОНАРНЫХ ЛИМФАТИЧЕСКИХ УЗЛАХ // ДИАГНОСТИЧЕСКАЯ И ИНТЕРВЕНЦИОННАЯ РАДИОЛОГИЯ ‒2013. ‒ T. 7, № 4-4. ‒ C. 9-14.
303. Torabi S. J., Benchetrit L., Spock T., Cheraghlou S., Judson B. L. Clinically node-negative head and neck mucosal melanoma: An analysis of current treatment guidelines & outcomes // Oral Oncol. ‒ 2019. ‒ T. 92. ‒ C. 67-76.
304. Ramesh M., Nanda S., Misra B. Mucosal melanoma of the head-and-neck region: A single institutional clinical experience // South Asian J Cancer. ‒ 2019. ‒ T. 8, № 1. ‒ C. 26.
305. Prinzen T., Klein M., Hallermann C., Wermker K. Primary head and neck mucosal melanoma: Predictors of survival and a case series on sentinel node biopsy // J Craniomaxillofac Surg. ‒ 2019.10.1016/j.jcms.2019.06.012.
306. Moya-Plana A., Mangin D., Dercle L., Taouachi R., Casiraghi O., Ammari S., Nguyen F., Temam S., Robert C., Gorphe P. Risk-based stratification in head and neck mucosal melanoma // Oral Oncol. ‒ 2019. ‒ T. 97. ‒ C. 44-49.
307. Yao J. J., Zhang F., Zhang G. S., Deng X. W., Zhang W. J., Lawrence W. R., Zou L., Zhang X. S., Lu L. X. Efficacy and safety of primary surgery with postoperative radiotherapy in head and neck mucosal melanoma: a single-arm Phase II study // Cancer Manag Res. ‒ 2018. ‒ T. 10. ‒ C. 6985-6996.
308. Comoglu S., Polat B., Celik M., Sahin B., Enver N., Keles M. N., Sari S. O. Prognostic factors in head and neck mucosal malignant melanoma // Auris Nasus Larynx. ‒ 2018. ‒ T. 45, № 1. ‒ C. 135-142.
309. Игнатова А. В., Мудунов А. М., Подвязников С. О. Особенности клинического течения меланомы слизистых оболочек головы и шеи. обзор литературы // Опухоли головы и шеи. ‒ 2015. ‒ T. 5, № 4. ‒ C. 48-52.
310. Moreno M. A., Roberts D. B., Kupferman M. E., DeMonte F., El-Naggar A. K., Williams M., Rosenthal D. S., Hanna E. Y. Mucosal melanoma of the nose and paranasal sinuses, a contemporary experience from the M. D. Anderson Cancer Center // Cancer. ‒ 2010. ‒ T. 116, № 9. ‒ C. 2215-23.
311. Li W., Yu Y., Wang H., Yan A., Jiang X. Evaluation of the prognostic impact of postoperative adjuvant radiotherapy on head and neck mucosal melanoma: a meta-analysis // BMC Cancer. ‒ 2015. ‒ T. 15. ‒ C. 758.
312. Zhu W., Zou B., Wang S. Clinicopathological Features and Prognosis of Sinonasal Mucosal Malignant Melanoma: A Retrospective Study of 83 Cases in a Chinese Population // ORL J Otorhinolaryngol Relat Spec. ‒ 2016. ‒ T. 78, № 2. ‒ C. 94-104.